Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Rahika 150mg Tablet 1
Rahika 150mg Tablet 2

Rahika 150mg Tablet

Capmatinib (150mg)
Genuine
Authenticity Assured
Prescription
required
NPPA Regulated
Show Details
Rahika 150mg Tablet is an anticancer medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic). It works by blocking a protein that promotes cancer cell growth, helping slow or stop cancer cell growth.

Written By Dr. Lipika Khurana, PGDHHM, BDS,
Reviewed By Dr. Sachin Gupta, MD Pharmacology, MBBS,
Last updated on 12 Nov 2026 | 04:58 PM (IST)
₹13592
MRP ₹13593.75
(Inclusive of applicable taxes)
12 tablets
Get by Monday, 16 November
Delivery Icon
Location Icon
Gurgaon
 
 
0
footer-icon

Payment, Returns & Expiry

Online payment only

To meet compliance, this product is available with online payment. Thanks for your patience!

We don’t take this product back

Products such as this are non-returnable to make sure that the next person doesn’t get a used item

Product expires after Feb, 2027

Expiry date may vary by batch. All batches have a 3-month shelf life from the date of dispatch.

Price Info

MRP may vary by batch. Any additional charges, including packaging, handling, shipping or delivery charges, will be clearly disclosed before purchase.

Save more with additional offers

offer icon
Flat ₹50 cashback. T&C Apply*
Flat ₹50 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
chevron icon
offer icon
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Flat ₹50 cashback. T&C Apply*
Flat ₹50 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
chevron icon
offer icon
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
The content is shown in English
Rahika 150mg Tablet 1
Rahika 150mg Tablet 2

Product introduction

Rahika 150mg Tablet can be taken with or without food, preferably at the same times every day. Your doctor will determine the appropriate dose and may adjust it depending on your response to treatment and any side effects you experience. Take it exactly as prescribed, and do not change the dose or stop taking it without consulting your doctor.


The most common side effects of Rahika 150mg Tablet include swelling of the hands or feet (edema), nausea, muscle or bone pain (musculoskeletal pain), fatigue, vomiting, shortness of breath, cough, and decreased appetite. This medicine may also cause serious side effects, including lung inflammation, liver problems, pancreatic problems, and allergic reactions. Tell your doctor immediately if you develop new or worsening breathing difficulties, a persistent cough, fever, yellowing of the skin or eyes, severe abdominal pain, or signs of an allergic reaction.


Before taking Rahika 150mg Tablet, inform your doctor if you have lung or breathing problems, liver problems, pancreatic problems, or are taking any other medicines. This medicine may increase your skin's sensitivity to sunlight, so limit direct sun exposure and use sunscreen or protective clothing during treatment.


Rahika 150mg Tablet can harm an unborn baby and should be avoided during pregnancy. Both women who can become pregnant and men with female partners who can become pregnant should use effective contraception during treatment and for at least one week after the last dose. Breastfeeding should also be avoided during treatment and for one week after the last dose.

Benefits of Rahika Tablet

Treatment of Metastatic Non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is a type of lung cancer that can spread to other parts of the body. Rahika 150mg Tablet is a targeted anticancer medicine used to treat adults with metastatic NSCLC whose tumors have a specific genetic alteration called MET exon 14 skipping. It works by blocking the activity of the abnormal MET protein, which helps slow or stop the growth and spread of cancer cells. Rahika 150mg Tablet helps shrink tumors and control cancer progression. It is an effective treatment option for patients with this specific genetic alteration.

Side effects of Rahika Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Rahika
  • Edema (swelling)
  • Nausea
  • Musculoskeletal (bone, muscle or joint) pain
  • Fatigue
  • Vomiting
  • Breathlessness
  • Cough
  • Decreased appetite

How to use Rahika Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rahika 150mg Tablet may be taken with or without food.

How Rahika Tablet works

Rahika 150mg Tablet works by blocking the activity of a protein called MET, including its abnormal form caused by a genetic alteration known as MET exon 14 skipping. This blocks signals that promote the growth and survival of cancer cells, helping slow or stop their growth.

Quick tips

  • Take Rahika 150mg Tablet exactly as prescribed by your doctor. Swallow it whole without crushing, breaking, or chewing. Do not change your dose or stop treatment without consulting your doctor.
  • Your doctor will perform blood tests before and during treatment to monitor your liver and pancreatic function. Do not miss any scheduled tests or follow-up appointments.
  • Inform your doctor immediately if you develop a new or worsening cough, fever, difficulty breathing, or shortness of breath, as these may indicate serious lung problems.
  • Contact your doctor if you notice yellowing of the skin or eyes, dark urine, severe stomach pain, or persistent nausea and vomiting, as these may indicate liver or pancreatic problems.
  • Rahika 150mg Tablet may make your skin more sensitive to sunlight. Limit direct sun exposure and use sunscreen or wear protective clothing when outdoors.
  • Inform your doctor about all medicines you are taking, including vitamins, and herbal supplements, as some may interact with Rahika 150mg Tablet.
  • Use effective contraception during treatment and for 1 week after the last dose. Avoid breastfeeding during treatment and for 1 week after the last dose.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Rahika 150mg Tablet. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Rahika 150mg Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feeding

Breast feeding

UNSAFE
Rahika 150mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving

Driving

SAFE
Rahika 150mg Tablet does not usually affect your ability to drive.
Kidney

Kidney

SAFE IF PRESCRIBED
Rahika 150mg Tablet is safe to use in patients with kidney disease. No dose adjustment is recommended.
Liver

Liver

CAUTION
Rahika 150mg Tablet should be used with caution in patients with liver disease. Dose adjustment may be needed.

Interaction with drugs

Taking Rahika with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Severe

Apalutamide (Oral Route)

Concomitant use should be avoided. Please consult with your doctor. Apalutamide may increase the metabolism of Capmatinib.
Moderate

Caffeine (Oral Route)

If concurrent use is essential, watch out for symptoms such as acute confusional state, difficulty in sleeping, frequent urge to urinate or fever and consult your doctor if you experience them. They may adjust the doses as per the observations. Capmatinib may raise blood levels of Caffeine.
Moderate

Rabeprazole (Oral Route)

Rabeprazole may reduce blood levels of Capmatinib. Rabeprazole may reduce blood levels of Capmatinib.
Moderate

Rabeprazole (Injection Route)

Rabeprazole may reduce blood levels of Capmatinib. Rabeprazole may reduce blood levels of Capmatinib.
Moderate

Dabigatran Etexilate (Oral Route)

Capmatinib may raise blood levels of Dabigatran Etexilate. Capmatinib may raise blood levels of Dabigatran Etexilate.

Frequently asked questions

Rahika 150mg Tablet is a prescription medicine used to treat adults with a kind of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be removed by surgery and whose tumors have an abnormal gene.
This treatment may harm a baby developing in the womb. It is important not to conceive during and for 1 week after your last dose of Rahika 150mg Tablet. Talk to your doctor about effective contraception before starting the treatment.
This medicine is to be taken twice a day with or without food or as advised by your doctor. It is advisable not to change your dose or stop taking this medicine unless the doctor tells you to.
You will be prescribed a liver test to assess how well your liver is working before and during the treatment. Inform your doctor immediately if you develop any signs and symptoms of liver problems, including your skin or the white part of your eyes turning yellow, nausea, vomiting, loss of appetite, dark-colored urine, or stomach pain.
Yes, Rahika 150mg Tablet is the first targeted therapy designed specifically for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping.
Both chemotherapy and targeted therapy are two effective methods for cancer therapy. The difference is that chemotherapy can also kill normal cells when destroying cancer cells. On the other hand, targeted therapy does not affect normal cells while killing the targeted cancer cells.
Your skin may become sensitive to the sun (photosensitivity) during treatment with this medicine. Use a sunscreen or wear clothes that cover your skin during your treatment to limit direct sunlight exposure.
Nausea and fatigue or tiredness are some of the common side effects of this medicine. Eat smaller, more frequent meals to reduce the feeling of nausea. Avoid food that is salty, spicy, fried, or fatty. Get plenty of rest and do light exercise daily to keep yourself active and reduce fatigue.
You can continue with your normal diet unless your doctor tells you otherwise. However, it is advisable to sip water regularly to prevent dehydration, eat small, simple but nourishing snacks every few hours rather than large meals, and suck on hard candy or popsicles to prevent nausea and vomiting.
You might experience swelling in different parts of your body while taking Rahika 150mg Tablet. Inform your doctor, as they may change your dose, temporarily stop, or permanently stop the treatment according to the side effects.

Fact Box

Chemical Class

Triazolopyridazine derivative

Habit Forming

No

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Tyrosine Kinase Inhibitors (TKIs)
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Vendor Details

Country of origin: Germany
A licensed vendor partner from your nearest location will deliver Rahika 150mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Why we need a prescription?
close sheet